GS
Gerald T Stanewick
Director

Gerald T Stanewick insider trades: Nastech Pharmaceutical (NSTK) stock buys and sales

Director, Nastech Pharmaceutical Last trade May 12, 2008 12 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2005
1
Company
last trade 2008

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Gerald reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 12, 2008NSTK↑ Buy$11K
Mar 19, 2008NSTK↑ Buy$12K
Sep 10, 2007NSTK↓ Sell$60K
Mar 8, 2007NSTK↑ Buy$21K
Dec 11, 2006NSTK↑ Buy$24K
Dec 11, 2006NSTK↑ Buy$11K
Oct 6, 2006NSTK↑ Buy$47K
Apr 5, 2006NSTK↓ Sell$52K
May 16, 2005NSTK↓ Sell$109K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Gerald T Stanewick's insider trades

Gerald T Stanewick is a director at Nastech Pharmaceutical (NSTK). Since May 16, 2005, Gerald has reported 6 open-market purchases worth $127K and 3 sales worth $221K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (3 filings), gifts (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NSTK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.